There is a need to identify patients with obstructive sleep apnea after a weight-loss drug was approved for treatment of the ...

The game is afoot in the obesity space as GLP-1 rivals Eli Lilly and Novo Nordisk take their showdown to a new level. Lilly ...

Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...

Intuitive secured a single port robot clearance, Resmed bought sleep testing facility Virtuox, and Precision Neuroscience ...

Zepbound (tirzepatide) is a weekly injectable weight-loss medication. It can be purchased online or in person with a valid ...

Resmed beat Wall Street estimates for third-quarter profit on Wednesday, driven by demand for its sleep apnea devices used to manage the common sleep disorder.

The trial isn’t definitive, however. It’s one of several that Lilly is running in diabetes, obesity and other related conditions like sleep apnea. Its main obesity trial won’t wrap until at ...

The trial is one of several that Lilly is running to test the drug, called orforglipron, in diabetes, obesity and other related conditions like sleep apnea. Investors and analysts had expected it ...

Obstructive sleep apnea (OSA) is a long-term condition where ... A cost assistance program is available from Eli Lilly and Company, the maker of Zepbound. It may reduce the amount you pay.

In December 2024, the FDA affirmed that the shortage of tirzepatide, marketed as Zepbound for weight loss, had ended, ...

Eli Lilly, the drug company that makes Zepbound ... Zepbound is a medication that may help you lose weight or improve your obstructive sleep apnea. A prescription from a licensed healthcare ...